Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Acquisition

18 May 2022 07:00

RNS Number : 9061L
Sopheon PLC
18 May 2022
 

SOPHEON PLC

("Sopheon" or the "Company")

 

Acquisition of Solverboard accelerates Sopheon growth strategy

Sopheon, the leading international provider of software and services for Enterprise Innovation Management solutions, is pleased to announce the acquisition of the business and assets of Solverlink Limited (trading as Solverboard® "Solverboard"), a UK based cloud-based business specializing in the front-end of innovation management.

Solverboard's multi-tenant, SaaS product is used by both individual innovators and product professionals, and is sold using an online, product-led growth ("PLG") model. Solverboard brings the innovation and product needs of professionals together so that they can focus on addressing front-end innovation challenges, increasing time to value by helping companies dynamically find, align, test and deliver the best innovation and product ideas from employees and customers.

Rationale for acquisition

In our last annual report we noted that Sopheon will be introducing new cloud-based applications this year, providing value to individual and workgroup users in the corporate ecosystem, alongside and integrated with the group's Accolade® enterprise software. These new applications are intended to drive lead generation for Accolade, as well as being stand-alone solutions that solve individual and workgroup productivity needs. The acquisition of Solverboard brings PLG capabilities into Sopheon more rapidly than previously planned, and accelerates this SaaS strategy from both functional and go-to-market perspectives.  Sopheon will continue to offer a free version of Solverboard and a paid subscription with more advanced features. We expect to introduce additional Sopheon products to be sold through the Solverboard channel by the end of the year.

Deal structure and consideration

The transaction is structured as a business and asset purchase. Initial consideration comprises £500,000 in cash and £250,000 in shares issued at £6 per share. An additional, contingent deferred earn-out of up to £1.55 million is payable over the next two years, linked to Annual Recurring Revenue ("ARR") targets. The earn-out consideration will be satisfied by up to £900,000 in shares issued at £6 per share, with the balance in cash. The cash consideration component of the acquisition is being funded out of existing and healthy cash resources. The share consideration elements are subject to lock in and orderly market restrictions.

 

Since inception, over £3 million has been invested in the Solverboard business and products by Solverboard's founders and management. A new platform was launched in September 2021, and has secured a number of customers to its free tier but is yet to generate material revenues. The costs of the business will be absorbed into Sopheon's current operating plans, through the reprioritization of planned spend.

Greg Coticchia, CEO of Sopheon said: "This acquisition is another step in our mission to provide the most comprehensive innovation system for the world's best companies. As well as its functional capabilities in the front end of innovation, adding Solverboard's expertise immediately brings us deep PLG go-to-market capabilities that were on our development roadmap. This is the second acquisition of a cloud-native, multi-tenant SaaS solution by Sopheon in the past six months. We look to the Solverboard and ROI Blueprints acquisitions to accelerate Sopheon's shift to a pure play SaaS model and associated ARR growth."

Solverboard founder and CEO Phil Atherton added: "It is very exciting to become part of Sopheon, a leader in the Enterprise Innovation Management space. Our companies are a perfect fit in vision, purpose and culture. Solverboard's product-led "go to market" capability for innovation and product professionals is highly complementary to Sopheon's market-leading sales-led enterprise go-to-market capability. We believe this combination will be pretty unique in our sector."

 

 

Allotment and issue of shares

Sopheon has allotted 41,667 new Ordinary Shares of 20 pence each in the Company to satisfy the share component of the initial consideration. Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 23 May 2022. The new Ordinary Shares will rank pari-passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,594,992. The Company does not hold any shares in treasury. Accordingly, the figure of 10,594,992 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information contact:

Andy Michuda (Executive Chairman)Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Edward Whiley (Corporate Finance)

Alice Lane / Sunila de Silva (ECM)

finnCap

+ 44 (0) 20 7220 0500

 

Sopheon, Accolade and Solverboard are trademarks of Sopheon plc. All other trademarks are the property of their respective owners.

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBKFBDPBKKPPD
Date   Source Headline
24th Jul 20199:05 amRNSSecond Price Monitoring Extn
24th Jul 20199:00 amRNSPrice Monitoring Extension
24th Jul 20197:00 amRNSTrading Update
13th Jun 20191:06 pmRNSResult of AGM
13th Jun 20197:00 amRNSAccolade 12.3
13th Jun 20197:00 amRNSAGM Statement
11th Jun 20191:32 pmRNSIssue of Equity
15th May 20197:00 amRNSSopheon Expands Customer Foothold in Asia
13th May 20199:14 amRNSIssue of Equity
28th Mar 20197:00 amRNSSopheon and National Foods Limited Partnership
21st Mar 20197:00 amRNSFinal Results
5th Feb 20197:00 amRNSIssue of Equity
29th Jan 20197:00 amRNSTrading Update
24th Jan 20194:41 pmRNSSecond Price Monitoring Extn
24th Jan 20194:35 pmRNSPrice Monitoring Extension
17th Jan 20197:00 amRNSAccolade Release 12.2
11th Jan 20197:00 amRNSTrading Update
8th Jan 20197:00 amRNSSopheon Partners with The Hershey Company
18th Dec 20182:53 pmRNSIssue of Equity
16th Nov 201812:54 pmRNSIssue of Equity
31st Oct 20185:18 pmRNSIssue of Equity
23rd Oct 20187:00 amRNSSopheon Awarded The Nature's Bounty Co. Business
8th Oct 20189:05 amRNSSecond Price Monitoring Extn
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSTrading Update
10th Sep 20187:00 amRNSDoosan Bobcat Awards Sopheon Innovation Contract
7th Sep 20185:48 pmRNSIssue of Equity
29th Aug 20183:54 pmRNSIssue of Equity & Holdings in Company
28th Aug 20187:00 amRNSAccolade Enterprise Innovation Management
23rd Aug 20187:00 amRNSHalf Yearly Report
19th Jul 201811:05 amRNSSecond Price Monitoring Extn
19th Jul 201811:00 amRNSPrice Monitoring Extension
19th Jul 20187:00 amRNSTrading Update
5th Jul 20189:40 amRNSGrant of Options / PDMR Dealing
3rd Jul 20189:24 amRNSIssue of Equity
13th Jun 20182:37 pmRNSIssue of Equity
7th Jun 201812:09 pmRNSResult of AGM
7th Jun 20187:00 amRNSAGM Statement
31st May 20182:56 pmRNSIssue of Equity
17th May 20188:01 amRNSResult of Secondary Placing
16th May 20183:05 pmRNSProposed Secondary Placing
15th May 20187:00 amRNSIssue of Equity
27th Apr 20183:59 pmRNSIssue of Equity
29th Mar 20187:00 amRNSAccolade Release 12.0
23rd Mar 20183:56 pmRNSIssue of Equity
23rd Mar 20187:00 amRNSIssue of Equity
22nd Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSSopheon named in Annual Reader's Choice List
12th Feb 20189:24 amRNSGrant of Options / PDMR dealing
5th Feb 20183:35 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.